(Q41658240)

6 October 2017

1 reference

title

Mucocutaneous features of autoimmune blistering diseases (English)

1 reference

6 October 2017

Weinberg MA

1

1 reference

6 October 2017

Insler MS

series ordinal

2

1 reference

6 October 2017

Campen RB

series ordinal

3

1 reference

6 October 2017

publication date

1 November 1997

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

6 October 2017

published in

1 reference

6 October 2017

volume

84

1 reference

6 October 2017

issue

5

1 reference

6 October 2017

page(s)

517-534

1 reference

Pemphigus and pemphigoid. A review of the advances made since 1964.

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

A case of pemphigus vulgaris in a six-year-old girl

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Oral pemphigus vulgaris in a 6-year-old girl

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Chronic pemphigus vulgaris of the gingiva. A case report with a 6-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Intraoral pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Early detection of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Nikolsky sign; page from notable contributors to the knowledge of dermatology.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

An Electron Microscopic Study on Pemphigus Vulgaris of the Mouth and the Skin with Special Reference to the Intercellular Cement*

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Pemphigus vlugaris; a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Ultrastructural study of clinically uninvolved skin of patients with pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Relationship between the serum autoantibody titers and the clinical activity of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

In vitro complement activation by intercellular antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

An immunohistological study of desmosomal components in pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Plakoglobin: a protein common to different kinds of intercellular adhering junctions

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Ultrastructural alterations associated with in vivo and in vitro bound pemphigus antibodies in cultured oral epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Treatment of pemphigus vulgaris with cyclosporine. .

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Treatment of pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Photopheresis: a Clinically Relevant Immunobiologic Response Modifier

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Pemphigus vulgaris treated with photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

1 reference

7 January 2021

Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Paraneoplastic pemphigus, pemphigus vulgaris, and pemphigus foliaceus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Human autoantibodies against desmoplakins in paraneoplastic pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Paraneoplastic pemphigus. A distinct autoimmune vesiculobullous disorder associated with neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Oral Lesions of Mucous Membrane Pemphigoid: A Study of 85 Cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases. Selective review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Clinical variants of pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Oral involvement in mucous membrane pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

HLA Antigens in Ocular Cicatricial Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Oral mucous membrane pemphigoid. A study of sixty-five patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Oral lesions in bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Bullous pemphigoid, cicatricial pemphigoid, and pemphigus vulgaris. A comparative clinical survey of 278 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Lesions induced by trauma in pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Benign mucous membrane (cicatricial) pemphigoid revisited: a clinical and immunological reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Vesiculo-bullous mucocutaneous disease: benign mucous membrane and bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectronmicroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Cicatricial pemphigoid: direct and indirect immunofluorescent studies

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Immunofluorescent studies in desquamative gingivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Direct immunofluorescence of detached gingival epithelium for diagnosis of cicatricial pemphigoid. Report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Immunofluorescence and Immunoelectron Microscopic Studies in Cicatricial Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Restriction of cicatricial pemphigoid antigens to the lamina densa: confirmation by indirect immunoelectron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

A 230-kD basic protein is the major bullous pemphigoid antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

The hemidesmosome: a target in auto-immune bullous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

The Major Cicatricial Pemphigoid Antigen Is a 180-kD Protein that Shows Immunologic Cross-Reactivities with the Bullous Pemphigoid Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Mucous membrane pemphigoid. Treatment experience at two institutions

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Modified topical steroid therapy for the treatment of oral mucous membrane pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Inhibition of lysosomal enzymes by dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Dapsone Suppresses Integrin-Mediated Neutrophil Adherence Function

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Treatment of cicatricial pemphigoid with tetracycline and nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

The treatment of desquamative gingival lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Idoxuridine-Induced Conjunctival Cicatrization

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Cicatricial pemphigoid in D-penicillamine treated patients with rheumatoid arthritis--a report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Desquamative gingivitis: a form of cicatricial pemphigoid?

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

The Pathogenesis of Dermatitis Herpetiformis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

The relationship between linear IgA disease and benign mucous membrane pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Chronic bullous disease of childhood with oral mucosal scarring

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Oral manifestations in linear IgA disease

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Linear IgA disease manifesting as recalcitrant desquamative gingivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Oral manifestations of linear IgA disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Linear IgA bullous dermatosis v dermatitis herpetiformis. Quantitative measurements of dermoepidermal alterations

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Cutaneous IgA subclasses in dermatitis herpetiformis and linear IgA disease

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Evidence that the IgA in patients with linear IgA disease is qualitatively different from that of patients with dermatitis herpetiformis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Linear IgA disease in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

A case of linear IgA disease presenting initially with IgG immune deposits

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

A case of linear IgA bullous dermatosis with atypical clinical and ultrastructural manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Small intestinal biopsies and HLA types in dermatitis herpetiformis patients with granular and linear IgA skin deposits

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Antigenic specificity of antibodies from patients with linear basement membrane deposition of IgA

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Dermatitis herpetiformis and linear IgA bullous dermatosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Linear IgA disease: a heterogeneous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Immunogold localization of the 97-kD antigen of linear IgA bullous dermatosis (LABD) detected with patients' sera

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Linear IgA bullous dermatosis of adults and children: an immunoelectron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

The treatment of benign chronic bullous dermatosis of childhood, and dermatitis herpetiformis and bullous pemphigoid beginning in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Vancomycin-associated linear IgA dermatosis. A report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Epidermolysis bullosa acquisita--a pemphigoid-like disease

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Epidermolysis bullosa acquisita--a sign of cicatricial pemphigoid?

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Severe ocular involvement in a patient with epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Epidermolysis bullosa acquisita: ultrastructural and immunological studies

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Differentiating Anti-Lamina Lucida and Anti-Sublamina Densa Anti-BMZ Antibodies by Indirect Immunofluorescence on 1.0 M Sodium Chloride-Separated Skin

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Epidermolysis Bullosa Acquisita With Electron Microscopical Studies

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Treatment of epidermolysis bullosa acquisita with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Localized linear bullous eruption of systemic lupus erythematosus in a child

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Vesiculobullous systemic lupus erythematosus. A report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Herpetiform Blisters in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Bullous systemic lupus erythematosus: revised criteria for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

Bullous systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990269-9

7 January 2021

10.1016/S1079-2104(97)90269-9

Identifiers

DOI

1 reference

6 October 2017

1 reference